Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × abemaciclib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 60 Neoplasm Metastasis 13 Brain Neoplasms 9 Endometrial Neoplasms 8 Prostatic Neoplasms 7 Glioblastoma 7 Ovarian Neoplasms 6 Neoplasms 6 Triple Negative Breast Neoplasms 5 Sarcoma 4 Glioma 4 Recurrence 3 Meningioma 3 Carcinoma, Non-Small-Cell Lung 3 Unilateral Breast Neoplasms 2 Sarcoma, Ewing 2 Osteosarcoma 2 Neoplasms by Site 2 Liposarcoma 2 Fallopian Tube Neoplasms 2 Ependymoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Breast Diseases 2 Venous Thromboembolism 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1

Interventions

nilotinib 6 asciminib 6 Dasatinib 6 Imatinib Mesylate 5 bosutinib 4 Cyclophosphamide 4 fludarabine phosphate 3 Whole-Body Irradiation 3 ruxolitinib 2 ponatinib 2 letermovir 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Melphalan 2 Cyclosporine 2 Busulfan 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 olverembatinib 1 decitabine and cedazuridine drug combination 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Stem Cell Transplantation 1 Specimen Handling 1 Sirolimus 1 Rituximab 1 Practice Management, Medical 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡